[ad_1] Shoddy conditions at factories in India have sickened Americans and stoked a chemotherapy-drug shortage for cancer patients, raising calls for a more-resilient generic-drug supply. [ad_2] Source link
Tag: Cancer Drugs
Merck Challenges U.S. Government’s New Powers to Negotiate Drug Prices
[ad_1] The drugmaker filed a lawsuit saying Medicare’s drug-price negotiation program violates the company’s constitutional rights. [ad_2] Source link
FDA Allows Imports of China-Made Chemotherapy to Ease U.S. Shortage
[ad_1] Health In temporary move, Chinese drugmaker will be able to ship its cisplatin chemotherapy even though it hasn’t been FDA approved [ad_2] Source link
Bristol-Myers CEO Giovanni Caforio to Step Down
[ad_1] Chief Commercialization Officer Christopher Boerner will take over after Giovanni Caforio retires, the company said. [ad_2] Source link
Pfizer Agrees to Buy Seagen for $43 Billion
[ad_1] The New York drugmaker would pay $229 a share in cash for the biotech company and its pioneering cancer treatments. [ad_2] Source link
WSJ News Exclusive | New Drugs for Cancer, Rare Disease Can Now Cost More Than $20,000 a Month
[ad_1] WSJ News Exclusive Health Trend follows rising pressure on companies to rein in repeat or annual price hikes for older drugs [ad_2] Source link
Seagen’s Cancer Therapy Is Making It a Takeover Target
[ad_1] Health Novel cancer agents could shore up aging pharmaceutical portfolios for big drugmakers [ad_2] Source link
WSJ News Exclusive | Pfizer in Talks to Acquire Seagen in Deal Likely Valued at More Than $30 Billion
[ad_1] WSJ News Exclusive Deals Potential deal would help the drug company add to its lineup of cancer treatments [ad_2] Source link
U.S. Stocks Rise After Indexes Post Worst Week of 2023
[ad_1] Markets U.S. Markets Markets have been rocked in February by signs of stubborn inflation [ad_2] Source link